These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32235718)

  • 41. Managing relapsed and refractory Hodgkin lymphoma.
    Brice P
    Br J Haematol; 2008 Apr; 141(1):3-13. PubMed ID: 18279457
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A label-free nano-liquid chromatography-mass spectrometry approach for quantitative serum peptidomics in Crohn's disease patients.
    Nanni P; Levander F; Roda G; Caponi A; James P; Roda A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3127-36. PubMed ID: 19683480
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Paediatric and adolescent Hodgkin lymphoma: information derived from diffuse organ uptake of 18 F-fluorodeoxyglucose on pre-treatment and on interim PET/CT.
    Jorgov L; Montravers F; Balogova S; Ragu C; Pacquement H; Leblanc T; Abbou S; Ducou-Lepointe H; Landman-Parker J; Talbot JN
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1220-30. PubMed ID: 26660144
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of human serum protein targets of Qianggu Decoction () in primary type I osteoporosis based on tandem mass tag labeling and liquid chromatography-tandem mass spectrometry technology.
    Liang BC; Shi XL; Li CW; Shi ZY; He WT; Yao JL; Kong LC; Li XY
    Chin J Integr Med; 2017 Oct; 23(10):747-754. PubMed ID: 27389089
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of intraoral mechanical stress application on the expression of a force-responsive prognostic marker associated with system disease progression.
    Zhang Y; Kou X; Jiang N; Liu Y; Tay FR; Zhou Y
    J Dent; 2017 Feb; 57():57-65. PubMed ID: 27979689
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimal treatment for relapsing patients with Hodgkin lymphoma.
    Sibon D; Brice P
    Expert Rev Hematol; 2009 Jun; 2(3):285-95. PubMed ID: 21082970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes.
    Lepedda AJ; Lobina O; Rocchiccioli S; Nieddu G; Ucciferri N; De Muro P; Idini M; Nguyen HQ; Guarino A; Spirito R; Formato M
    J Diabetes Complications; 2016 Jul; 30(5):880-6. PubMed ID: 27037039
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hodgkin lymphoma in children and adolescents: improving the therapeutic index.
    Kelly KM
    Hematology Am Soc Hematol Educ Program; 2015; 2015():514-21. PubMed ID: 26637767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunotherapy for the treatment of Hodgkin lymphoma.
    Donato EM; Fernández-Zarzoso M; De La Rubia J
    Expert Rev Hematol; 2017 May; 10(5):417-423. PubMed ID: 28359170
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma.
    Rancea M; Monsef I; von Tresckow B; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD009411. PubMed ID: 23784872
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of CALM as the potential serum biomarker for predicting the recurrence of nasopharyngeal carcinoma using a mass spectrometry-based comparative proteomic approach.
    Meng H; Zhu X; Li L; Liang Z; Li X; Pan X; Zeng F; Qu S
    Int J Mol Med; 2017 Oct; 40(4):1152-1164. PubMed ID: 28849027
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential expressions of plasma proteins in systemic lupus erythematosus patients identified by proteomic analysis.
    Madda R; Lin SC; Sun WH; Huang SL
    J Microbiol Immunol Infect; 2019 Oct; 52(5):816-826. PubMed ID: 30170966
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitative proteomics analysis with iTRAQ in human lenses with nuclear cataracts of different axial lengths.
    Zhou H; Yan H; Yan W; Wang X; Ma Y; Wang J
    Mol Vis; 2016; 22():933-43. PubMed ID: 27559289
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased circulating CD3
    Batorov EV; Pronkina NV; Tikhonova MA; Kryuchkova IV; Sergeevicheva VV; Sizikova SA; Ushakova GY; Aristova TA; Batorova DS; Shishkova IV; Gilevich AV; Shevela EY; Ostanin AA; Chernykh ER
    Leuk Lymphoma; 2019 Oct; 60(10):2488-2497. PubMed ID: 31609150
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ABRF Proteome Informatics Research Group (iPRG) 2015 Study: Detection of Differentially Abundant Proteins in Label-Free Quantitative LC-MS/MS Experiments.
    Choi M; Eren-Dogu ZF; Colangelo C; Cottrell J; Hoopmann MR; Kapp EA; Kim S; Lam H; Neubert TA; Palmblad M; Phinney BS; Weintraub ST; MacLean B; Vitek O
    J Proteome Res; 2017 Feb; 16(2):945-957. PubMed ID: 27990823
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein signatures as potential surrogate biomarkers for stratification and prediction of treatment response in chronic myeloid leukemia patients.
    Alaiya AA; Aljurf M; Shinwari Z; Almohareb F; Malhan H; Alzahrani H; Owaidah T; Fox J; Alsharif F; Mohamed SY; Rasheed W; Aldawsari G; Hanbali A; Ahmed SO; Chaudhri N
    Int J Oncol; 2016 Sep; 49(3):913-33. PubMed ID: 27573699
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protein expression profiles in pediatric multiple sclerosis: potential biomarkers.
    Rithidech KN; Honikel L; Milazzo M; Madigan D; Troxell R; Krupp LB
    Mult Scler; 2009 Apr; 15(4):455-64. PubMed ID: 19324981
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling.
    Cho WC; Yip TT; Yip C; Yip V; Thulasiraman V; Ngan RK; Yip TT; Lau WH; Au JS; Law SC; Cheng WW; Ma VW; Lim CK
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):43-52. PubMed ID: 14734450
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An application of mass spectrometry for quality control of biologicals: Highly sensitive profiling of plasma residuals in human plasma-derived immunoglobulin.
    Limonier F; Van Steendam K; Waeterloos G; Brusselmans K; Sneyers M; Deforce D
    J Proteomics; 2017 Jan; 152():312-320. PubMed ID: 27894965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.